4DX:ASX
4DMedical Ltd
၂.၃၇ A$
arrow_upward
+၀.၈၅%(+၀.၀၂၀) 1D
နို ၁၁, GMT+၁၁ ၁၆:၁၀:၀၉ · AUD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for 4DX...
Open
၂.၃၄ A$
High
၂.၄၆ A$
Low
၂.၃၃ A$
Mkt. cap
၁၄၂.၇၅ ဋေ
Avg. vol.
၅.၂၉ သန်း
Volume
၃.၅၈ သန်း
52-wk high
၇.၅၅ A$
52-wk low
၁.၄၀ A$
EPS
-၀.၃၈ A$
Shares outstanding
၆၀.၂၃ ကုဋေ
No. of employees
၁၈၁
Open
၂.၃၄ A$
High
၂.၄၆ A$
Low
၂.၃၃ A$
Mkt. cap
၁၄၂.၇၅ ဋေ
Avg. vol.
၅.၂၉ သန်း
Volume
၃.၅၈ သန်း
52-wk high
၇.၅၅ A$
52-wk low
၁.၄၀ A$
EPS
-၀.၃၈ A$
Shares outstanding
၆၀.၂၃ ကုဋေ
No. of employees
၁၈၁
News stories
From web sources and news partners
Barron's
·
ပြီးခဲ့သည့် ၂၃ မိနစ်
These Stocks Are Beating the S&P 500—and Have Steady Yields
Reuters
·
ပြီးခဲ့သည့် ၁၇ မိနစ်
Mapping the Market: S&P 500 at risk of further losses
FXStreet
·
ပြီးခဲ့သည့် ၁ နာရီ
S&P 500: Higher yields weigh on equities – Deutsche Bank
Yahoo Finance
·
ပြီးခဲ့သည့် ၅၂ မိနစ်
Why the S&P 500 Could Be Heading for a Repeat of 2018
Profile
4DMedical is a medical technology company, based in Australia and the United States.
4DMedical created X-ray Velocimetry Lung Ventilation Analysis Software based on the company's proprietary XV Technology. XV Technology uses patented algorithms adapted from advanced aerodynamics research to process and enhance X-ray and Computed Tomography images. Airflow is measured throughout all regions of the lung, across all phases of the breath—providing clinicians with quantitative lung ventilation data in a report.
4DMedical has commercialized its XV Technology via a Software as a Service model, where patients are scanned using existing imaging equipment and analyzed by 4DMedical remotely. Airflow is measured throughout all regions of the lung, across all phases of the breath, delivering the capability to quantify regional lung function throughout the respiratory cycle, at every location within the lung. The lung function data is provided to clinicians and patients in a report that includes color-coded lung images. This approach enables the detection of subtle functional losses before lung structure is irreversibly effected by the disease. Wikipedia
About 4DMedical Ltd